Design of a tumor homing cell-penetrating peptide for drug delivery

International Journal of Peptide Research and Therapeutics

Volumn 15, Issue 1, 2009, Pages 11-15

  Mäe, Maarja ^a   Myrberg, Helena ^a   El Andaloussi, Samir ^a   Langel, Ülo ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Cell penetrating peptide; Drug delivery; Homing peptide; Tumor targeting

Indexed keywords

CHLORAMBUCIL; CYSTEINYLARGINYLGLUTAMYLLYSYLALANINAMIDE; CYSTEINYLARGINYLGLUTAMYLLYSYLALANYLLEUCYLLEUCYLISOLEUCYL ISOLEUCYLLEUCYLARGINYLARGINYLARGINYLISOLEUCYLARGINYLLYSYLGLUTAMINYLALANYL HISTIDYLALANYLHISTIDYLSERYLLYSINAMIDE; LEUCYLLEUCYLISOLEUCYLISOLEUCYLLEUCYLARGINYLARGINYLARGINYL ISOLEUCYLARGINYLLYSYLGLUTAMINYLALANYLHISTIDYLALANYLHISTIDYLSERYLLYSINAMIDE; PEPTIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL SPECIFICITY; COMPARATIVE STUDY; CONTROLLED STUDY; DNA ALKYLATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG SYNTHESIS; HUMAN; HUMAN CELL; TUMOR CELL;

EID: 58849148499     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-008-9156-x     Document Type: Article

References (28)

1. CG Adair JC McElnay 1986 Studies on the mechanism of gastrointestinal absorption of melphalan and chlorambucil Cancer Chemother Pharmacol 17 1 95 98
2. W Arap R Pasqualini E Ruoslahti 1998 Chemotherapy targeted to tumor vasculature Curr Opin Oncol 10 6 560 565
3. D Derossi AH Joliot G Chassaing A Prochiantz 1994 The third helix of the Antennapedia homeodomain translocates through biological membranes J Biol Chem 269 14 10444 10450
4. A Elmquist M Lindgren T Bartfai Ü Langel 2001 VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions Exp Cell Res 269 2 237 244
5. A Elmquist M Hansen Ü Langel 2006 Structure-activity relationship study of the cell-penetrating peptide pVEC Biochim Biophys Acta 1758 6 721 729
6. M Essler E Ruoslahti 2002 Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature Proc Natl Acad Sci USA 99 4 2252 2257
7. J Folkman 1971 Tumor angiogenesis: therapeutic implications N Engl J Med 285 21 1182 1186
8. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70
9. T Holm H Johansson P Lundberg M Pooga M Lindgren Ü Langel 2006 Studying the uptake of cell-penetrating peptides Nat Protoc 1 2 1001 1005
10. M Ishiyama H Tominaga M Shiga K Sasamoto Y Ohkura K Ueno 1996 A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet Biol Pharm Bull 19 11 1518 1520
11. DB Longley PG Johnston 2005 Molecular mechanisms of drug resistance J Pathol 205 2 275 292
12. M Mäe Ü Langel 2006 Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery Curr Opin Pharmacol 6 5 509 514
13. M Mazel P Clair C Rousselle P Vidal JM Scherrmann D Mathieu J Temsamani 2001 Doxorubicin-peptide conjugates overcome multidrug resistance Anticancer Drugs 12 2 107 116
14. Myrberg H, Zhang L, Mäe M, Langel Ü (2007) Design of a tumor-homing cell-penetrating peptide. Bioconjug Chem
15. H Myrberg L Zhang M Mäe Ü Langel 2008 Design of a tumor-homing cell-penetrating peptide Bioconjug Chem 19 1 70 75
16. L O'Driscoll M Clynes 2006 Biomarkers and multiple drug resistance in breast cancer Curr Cancer Drug Targets 6 5 365 384
17. P Oh Y Li J Yu E Durr KM Krasinska LA Carver JE Testa JE Schnitzer 2004 Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy Nature 429 6992 629 635
18. L Panasci JP Paiement G Christodoulopoulos A Belenkov A Malapetsa R Aloyz 2001 Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair Clin Cancer Res 7 3 454 461
19. J Plescia W Salz F Xia M Pennati N Zaffaroni MG Daidone M Meli T Dohi P Fortugno Y Nefedova DI Gabrilovich G Colombo DC Altieri 2005 Rational design of shepherdin, a novel anticancer agent Cancer Cell 7 5 457 468
20. CS Portlock DS Fischer E Cadman WB Lundberg A Levy S Bobrow JR Bertino L Farber 1987 High-dose pulse chlorambucil in advanced, low-grade non-Hodgkin's lymphoma Cancer Treat Rep 71 11 1029 1031
21. C Rousselle P Clair JM Lefauconnier M Kaczorek JM Scherrmann J Temsamani 2000 New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy Mol Pharmacol 57 4 679 686
22. E Ruoslahti 2000 Targeting tumor vasculature with homing peptides from phage display Semin Cancer Biol 10 6 435 442
23. E Ruoslahti 2002 Specialization of tumour vasculature Nat Rev Cancer 2 2 83 90
24. E Ruoslahti T Duza L Zhang 2005 Vascular homing peptides with cell-penetrating properties Curr Pharm Des 11 28 3655 3660
25. A Sacchi A Gasparri F Curnis M Bellone A Corti 2004 Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin Cancer Res 64 19 7150 7155
26. A Sacchi A Gasparri C Gallo-Stampino S Toma F Curnis A Corti 2006 Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-alpha Clin Cancer Res 12 1 175 182
27. D Simberg T Duza JH Park M Essler J Pilch L Zhang AM Derfus M Yang RM Hoffman S Bhatia MJ Sailor E Ruoslahti 2007 Biomimetic amplification of nanoparticle homing to tumors Proc Natl Acad Sci USA 104 3 932 936
28. M Tan KH Lan J Yao CH Lu M Sun CL Neal J Lu D Yu 2006 Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide Cancer Res 66 7 3764 3772